Richard Osman says he will fight against AI copyright infringement – MSN
Richard Osman says he will fight against AI copyright infringement MSN
Archive for March, 2025
-
In: COPYRIGHT NEWS
-
In: PATENT NEWS
Reimagining the IP regime of the fashion industry in light of sustainability goals
Invitation to Start-Up Seminar of Spyros Sipetas in Intellectual Property / Fashion Law where Spyros will present his doctoral project: …
-
In: PATENT NEWS
Quoin Files US Patent Applications for Rare Disease Treatments – Dermatology Times
Quoin Files US Patent Applications for Rare Disease Treatments Dermatology Times
-
In: PATENT NEWS
Recap of 2024 U.S. Design Patent Drama: Here’s What We Know Now – JD Supra
Recap of 2024 U.S. Design Patent Drama: Here’s What We Know Now JD Supra
-
In: PATENT NEWS
Nirrin Technologies Granted Patent for Flow-Cell Technology – Genetic Engineering & Biotechnology News
Nirrin Technologies Granted Patent for Flow-Cell Technology Genetic Engineering & Biotechnology News
-
In: PATENT NEWS
Understanding the Different Types of Intellectual Property – The National Law Review
Patent Rights: A Barrier to Competition. Patents provide an exclusive right to inventors, allowing them to monopolize their innovations for up to …
-
In: PATENT NEWS
International Trade Commission Seeks Comments on Exclusion Orders
When the complainant alleges that an asserted patent is a standard essential patent … The National Law Review – National Law Forum LLC 2070 Green Bay …
-
In: PATENT NEWS
A Recent Tax Ruling Has Made ANDA Litigation Less Burdensome for Generics – JD Supra
In Actavis v. U.S., a case at the intersection of tax law and patent law, the Federal Circuit held that generic drug companies’ Hatch-Waxman…
-
In: PATENT NEWS
How Should a Licensing Commitment Affect the Availability of Injunctions at the ITC? – The National Law Review
How Should a Licensing Commitment Affect the Availability of Injunctions at the ITC? The National Law Review
-
In: PATENT NEWS
Roche Voids Biogen’s Protein Production Patent At EPO – Law360
Roche Voids Biogen’s Protein Production Patent At EPO Law360